Urea c-13
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
419 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lymphoma | D008223 | — | C85.9 | 24 | 53 | 8 | 2 | 2 | 75 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 23 | 33 | 3 | 1 | 1 | 46 |
| Mantle-cell lymphoma | D020522 | — | C83.1 | 10 | 24 | 4 | 1 | 1 | 31 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | 3 | 11 | 6 | 2 | 4 | 25 |
| Infections | D007239 | EFO_0000544 | — | 1 | — | 4 | 2 | 15 | 22 |
| Carcinoma | D002277 | — | C80.0 | 3 | 11 | 4 | 1 | 3 | 21 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 3 | 9 | 6 | 2 | 1 | 20 |
| Helicobacter infections | D016481 | EFO_1000961 | — | — | 1 | — | 1 | 11 | 13 |
| Communicable diseases | D003141 | — | — | — | — | — | 1 | 8 | 9 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | 1 | 1 | 4 | — | 6 |
Show 10 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Leukemia | D007938 | — | C95 | 12 | 31 | 5 | — | 1 | 39 |
| Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 16 | 26 | 5 | — | 1 | 38 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 6 | 21 | 3 | — | 1 | 28 |
| Follicular lymphoma | D008224 | — | C82 | 10 | 14 | 7 | — | 2 | 25 |
| B-cell lymphoma | D016393 | — | — | 11 | 14 | 3 | — | 1 | 22 |
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 10 | 15 | 4 | — | 1 | 22 |
| Burkitt lymphoma | D002051 | — | C83.7 | 6 | 16 | 3 | — | 1 | 20 |
| Hodgkin disease | D006689 | — | C81 | 9 | 13 | 2 | — | 2 | 20 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 8 | 12 | 2 | — | 1 | 19 |
| Neoplasms | D009369 | — | C80 | 10 | 8 | 1 | — | 1 | 15 |
Show 42 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Myeloid leukemia | D007951 | — | C92 | 4 | 7 | — | — | 1 | 9 |
| T-cell lymphoma | D016399 | — | — | 3 | 6 | — | — | 2 | 9 |
| Covid-19 | D000086382 | — | U07.1 | 1 | 2 | — | — | 4 | 7 |
| Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 1 | 5 | — | — | — | 6 |
| Hematopoietic stem cell transplantation | D018380 | — | — | 1 | 3 | — | — | 2 | 5 |
| Waldenstrom macroglobulinemia | D008258 | — | C88.0 | 3 | 3 | — | — | 1 | 5 |
| Glioblastoma | D005909 | EFO_0000515 | — | 2 | 5 | — | — | — | 5 |
| Hematologic neoplasms | D019337 | — | — | 2 | 3 | — | — | — | 4 |
| Preleukemia | D011289 | — | — | 2 | 4 | — | — | — | 4 |
| Syndrome | D013577 | — | — | 2 | 4 | — | — | — | 4 |
Show 93 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Dyspepsia | D004415 | EFO_0008533 | K30 | 1 | — | — | — | 5 | 6 |
| Stomach neoplasms | D013274 | EFO_0003897 | C16 | 1 | — | — | — | 5 | 6 |
| T-cell lymphoma cutaneous | D016410 | — | C84.A | 2 | — | — | — | 1 | 3 |
| Mycosis fungoides | D009182 | — | C84.0 | 1 | — | — | — | 1 | 2 |
| Pancreatic ductal carcinoma | D021441 | — | — | 1 | — | — | — | 1 | 2 |
| Porokeratosis | D017499 | — | L56.5 | 2 | — | — | — | — | 2 |
| Pachyonychia congenita | D053549 | — | — | 2 | — | — | — | — | 2 |
| Transplantation | D014180 | — | — | 1 | — | — | — | — | 1 |
| Hereditary breast and ovarian cancer syndrome | D061325 | — | — | 1 | — | — | — | — | 1 |
| Neurotoxicity syndromes | D020258 | — | G92 | 1 | — | — | — | — | 1 |
Show 10 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Acute kidney injury | D058186 | — | N17 | — | — | — | — | 5 | 5 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | — | — | — | — | 5 | 5 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | — | — | 4 | 4 |
| Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | — | — | — | 3 | 3 |
| Sepsis | D018805 | EFO_0001420 | A41.9 | — | — | — | — | 3 | 3 |
| Toxemia | D014115 | — | — | — | — | — | — | 3 | 3 |
| Diabetic nephropathies | D003928 | EFO_0000401 | — | — | — | — | — | 3 | 3 |
| Heart failure | D006333 | EFO_0003144 | I50 | — | — | — | — | 3 | 3 |
| Inborn genetic diseases | D030342 | EFO_0000508 | — | — | — | — | — | 2 | 2 |
| Renal insufficiency | D051437 | — | N19 | — | — | — | — | 2 | 2 |
Show 113 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 3,375 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
41 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use